(Q34569493)

3 August 2017

1 reference

title

Endoscopy in Barrett's esophagus. Surveillance during reflux management and new advances in the diagnosis and early detection of dysplasia (English)

1 reference

3 August 2017

1 reference

0 references

Jihad el Khoury

1

1 reference

PubMed ID

11901932

3 August 2017

Anand V Sahai

series ordinal

2

1 reference

PubMed ID

11901932

3 August 2017

language of work or name

1 reference

1 February 2002

1 reference

Chest surgery clinics of North America

3 August 2017

1 reference

3 August 2017

12

1 reference

3 August 2017

1

1 reference

3 August 2017

47-58

1 reference

High-resolution endoluminal sonography is a sensitive modality for the identification of Barrett's metaplasia

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Usefulness of cytopathology and histology in the evaluation of Barrett's esophagus in a community hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract. American Society for Gastrointestinal Endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Endoscopic ultraviolet-induced autofluorescence spectroscopy of the esophagus: tissue characterization and potential for early cancer diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

A cost analysis of outpatient care for patients with Barrett's esophagus in a managed care setting.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

1 reference

7 January 2021

Endoscopic surveillance of Barrett's esophagus: risk stratification and cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Practice patterns for surveillance of Barrett's esophagus in the united states

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Methylene blue staining and endoscopic ultrasound evaluation of Barrett's esophagus with low-grade dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Brush cytology in the diagnosis of neoplasia in Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

In vivo endoscopic optical coherence tomography of esophagitis, Barrett's esophagus, and adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Screening for specialized columnar epithelium with methylene blue: chromoendoscopy in patients with Barrett's esophagus and a normal control group.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

High-resolution cross-sectional imaging of the gastrointestinal tract using optical coherence tomography: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Optical coherence tomography: advanced technology for the endoscopic imaging of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Endoscopic photodynamic diagnosis: oral aminolevulinic acid is a marker of GI cancer and dysplastic lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Barrett's esophagus: update on screening, surveillance, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

The economic impact of the diagnosis of dysplasia in Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Spectroscopic diagnosis of esophageal cancer: new classification model, improved measurement system

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Feasibility of optical coherence tomography for high-resolution imaging of human gastrointestinal tract malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Diagnosis of specialized intestinal metaplasia by optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Biomarkers for malignancy in the columnar-lined esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

High-resolution endoscopic imaging of the GI tract using optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Surveillance for Barrett's oesophagus in the UK

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

In vivo endoscopic optical biopsy with optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Barrett's mucosa, Barrett's dysplasia and Barrett's carcinoma: diagnostic endoscopy without biopsy-taking does not suffice

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Laser-induced fluorescence for esophageal cancer and dysplasia diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Detection of adenocarcinoma in Barrett's oesophagus by means of laser induced fluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Value of cytology in detecting intestinal metaplasia and associated dysplasia at the gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

Predicting who will develop cancer: role of biopsy, flow cytometry, cell and genetic markers

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900065-6

7 January 2021

10.1016/S1052-3359(03)00065-6

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11901932